• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.30% Nasdaq Up 0.87%

    Peregrine Pharmaceuticals, Inc. (PPHM)

    -NasdaqCM
    0.31 Down 0.01(2.18%) 2:27PM EST - Nasdaq Real Time Price
    Prev Close:0.31
    Open:0.32
    Bid:0.31 x 1300
    Ask:0.31 x 1800
    1y Target Est:1.00
    Beta:1.55022
    Next Earnings Date:12-Dec-16PPHM Earnings announcement
    Day's Range:0.31 - 0.32
    52wk Range:0.29 - 1.31
    Volume:701,355
    Avg Vol (3m):1,176,140
    Market Cap:74.05M
    P/E (ttm):N/A
    EPS (ttm):-0.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PPHM

    Comparison

    Symbol% ChgMkt Cap
    PPHMDown 2.18%74.05M
    1 0.00%N/A
    AMGNDown 3.14%104.56B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,863.33
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Apr-17) :-0.15
    Quarterly EPS Est (Oct-16) :-0.03
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops monoclonal antibodies for the treatment of cancer in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback